Living with type I Usher syndrome: insights from patients and their parents

被引:6
作者
de Climens, Aude Roborel [1 ]
Tugaut, Beatrice [2 ]
Piscopo, Andrea [3 ]
Arnould, Benoit [2 ]
Buggage, Ronald [4 ]
Brun-Strang, Catherine [3 ]
机构
[1] Sanofi, Clin Outcomes Generat, 14 Espace Henri Vallee, F-69007 Lyon, France
[2] ICON Plc, Patient Ctr Outcomes, Lyon, France
[3] Sanofi, Global HEVA Early Portfolio, Chilly Mazarin, France
[4] Sanofi, Res & Dev, Chilly Mazarin, France
关键词
Usher syndrome; qualitative research; interviews; health-related quality of life; retinitis pigmentosa; QUALITY-OF-LIFE; VISION; HEALTH; QUESTIONNAIRE; IMPACT;
D O I
10.1080/13816810.2020.1737947
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Type 1 Usher syndrome (USH1) is a rare disease and major cause of genetic deaf-blindness. Deafness is present from birth while retinitis pigmentosa (RP) which typically presents during childhood is progressive leading to blindness. The aim of this research was to develop a disease model describing USH1 symptoms and their impact on patients' lives. Materials and Methods: Qualitative interviews were conducted with patients (pediatric and adult) and parents of children and adolescents with USH1. Interviewed subjects were enrolled through ophthalmologists from specialized eye centers in the USA and in France. Trained interviewers used semi-structured techniques to elicit concepts relevant to patients and their parents. Thematic analysis of interview transcripts led to the identification of concepts which were organized to generate a disease model. Results: A total of 18 patients (7 in the US; 11 in France)- 9 adults, 4 adolescents, and 5 children- and 9 mothers were interviewed. The most cited ocular symptoms were difficulty seeing at night and loss of peripheral vision. Interviewees reported limitations on Physical (e.g. difficulty moving), Mental (e.g. fear about falling), Social (e.g. difficulty discussing disease with others) and Role (e.g. difficulties at school/work) functioning. These impacts were, when possible, mitigated by coping strategies and support (e.g. using electronic devices, having a positive/proactive attitude). Conclusions: This research provides an overview of symptoms experienced by patients with USH1 and highlights the dramatic impact these have on patients' lives, allowing the identification of concepts of importance when evaluating therapeutic treatments in development for RP.
引用
收藏
页码:240 / 251
页数:12
相关论文
共 37 条
  • [1] Coping strategies, vision-related quality of life, and emotional health in managing retinitis pigmentosa: a survey study
    Anil, Krithika
    Garip, Gulcan
    [J]. BMC OPHTHALMOLOGY, 2018, 18
  • [2] [Anonymous], 2005, REFL PAP REG GUID US
  • [3] [Anonymous], RAR DIS COMM ISS DRU
  • [4] Atlas.Ti, 2012, VERS 7 0 SOFTW, DOI [10.1094/PDIS-11-11-0999-PDN, DOI 10.1094/PDIS-11-11-0999-PDN]
  • [5] Associations between specific measures of vision and vision-related quality of life in patients with Bothnia dystrophy, a defined type of retinitis pigmentosa
    Burstedt, Marie S. I.
    Monestam, Eva
    Sandgren, Ola
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (03): : 317 - 323
  • [6] Visual training and emotional state of people with retinitis pigmentosa
    Chacon-Lopez, Helena
    Pelayo, Francisco J.
    Lopez-Justicia, Maria D.
    Morillas, Christian A.
    Urena, Raquel
    Chacon-Medina, Antonio
    Pino, Begona
    [J]. JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2013, 50 (08) : 1157 - 1167
  • [7] Chassany O, 2002, DRUG INF J, V36, P209, DOI 10.1177/009286150203600127
  • [8] Impact of Retinitis Pigmentosa on Quality of Life, Mental Health, and Employment Among Young Adults
    Chaumet-Riffaud, Anne Elisabeth
    Chaumet-Riffaud, Philippe
    Cariou, Anaelle
    Devisme, Celine
    Audo, Isabelle
    Sahel, Jose-Alain
    Mohand-Said, Saddek
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 177 : 169 - 174
  • [9] Genetic disorders of the vestibular system
    Eppsteiner, Robert W.
    Smith, Richard J. H.
    [J]. CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2011, 19 (05) : 397 - 402
  • [10] European Network for Health Technology Assessment, 2016, EUNETHTA JA2 WP8 DEL